Influence instillation plasma rich in growth factors in endometrial cavity endometrial development in assisted reproduction.
Phase 1
- Conditions
- Women receiving cycle of oocytes outside or embryos (own / others), in the treatment of substituted cycle type.Less than 5 mm Endometrio despite 10 days with standard doses of estrogen therapy (6mg / 24h)Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
- Registration Number
- EUCTR2016-001716-38-ES
- Lead Sponsor
- IVI BILBAO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 32
Inclusion Criteria
- Women receiving cycle of oocytes outside or embryos (own / others), in the treatment of substituted cycle type.
- Less than 5mm despite 10 days with standard doses of estrogen therapy (6mg / 24h) Endometrio
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 32
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range 0
Exclusion Criteria
- History of pelvic inflammatory disease
- Risk of infection
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method